InDevR is a global leader in progressive new analytical technologies that enable accelerated development and manufacturing of vaccines and other biotherapeutics. Key products include our VaxArray portfolio of our game-changing multiplexed potency assays for vaccines and the Cypher One system for digital imaging and automated interpretation of hemagglutination assays.
Location: United States, Colorado, Boulder
Member count: 51-200
Total raised: $16M
Founded date: 2003
Investors 1
| Date | Name | Website |
| - | Adjuvant C... | adjuvantca... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 18.01.2023 | Series B | $9M | - | newsvoir.c... |
| 12.09.2019 | Series A | $7M | - | finsmes.co... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 18.01.2023 | InDevR rai... | Boulder, Colorado, United Stat... | - | - | newsvoir.c... |
| 01.07.2021 | InDevR Lau... | BOULDER, Colo., July 1, 2021 /... | - | - | en.prnasia... |
| 12.09.2019 | InDevR Rai... | BOULDER, CO, InDevR today an... | - | - | vcnewsdail... |
| 10.09.2019 | InDevR Rai... | InDevR, Inc., a Boulder, CO-ba... | USA | - | finsmes.co... |
| - | InDevR | “A team of researchers at USAM... | - | - | fastfounde... |